↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.3MSold on the market
1Companies
Sep 3, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202621:16 | Sep 1, 2026 | CORTCORCEPT THERAPEUTICS INC | Chief Development Officer | A · Grant | $56.69 | +328 | 4,313 | +8% | $19K | ||
| Aug 12, 202616:26 | Aug 10, 2026 | CORTCORCEPT THERAPEUTICS INC | Chief Development Officer | S · Sell10b5-1 | $113.43 | −16,300 | 3,985 | -80% | −$1.8M | ||
| Aug 12, 202616:26 | Aug 10, 2026 | CORTCORCEPT THERAPEUTICS INC | Chief Development Officer | M · Exercise10b5-1 | $21.65 | +16,300 | 20,285 | +409% | $353K | ||
| Aug 6, 202618:44 | Aug 4, 2026 | CORTCORCEPT THERAPEUTICS INC | Chief Development Officer | S · Sell10b5-1 | $113.12 | −3,700 | 3,985 | -48% | −$419K | ||
| Aug 6, 202618:44 | Aug 4, 2026 | CORTCORCEPT THERAPEUTICS INC | Chief Development Officer | M · Exercise10b5-1 | $21.65 | +3,700 | 7,685 | +93% | $80K |